What should I know first?

Selective serotonin reuptake inhibitors, or SSRIs, affect the return of serotonin into nerve cells. Sertraline is the example used here; Lustral is a UK product containing this medicine.

This UK lesson checks the mechanism against Lustral’s UK product information. It does not import the uses, age limits or formulations of the American Zoloft products.

This is a mechanism lesson, not a complete medicine guide. A diagram cannot choose treatment, predict your response, or tell you how to change a prescription.

How Brain Cells Communicate

Serotonin is a chemical messenger. At a chemical synapse, it is released into a small gap and can act at receptors. A transporter is a protein that carries a substance across a cell membrane.

The serotonin transporter, often shortened to SERT, returns serotonin into the sending nerve cell. This return is called reuptake. A transporter moves a messenger; a receptor responds to it.

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Serotonin: The messenger is shown outside the sending cell. SERT: The serotonin transporter returns serotonin into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Serotonin

    The messenger is shown outside the sending cell.

  2. SERT

    The serotonin transporter returns serotonin into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Qualitative serotonin-transport schematic; no measured counts, timing, binding geometry or prediction of response.
About this illustration

A transporter returns serotonin from the space outside the nerve cell into the cell. The arrow points inward; it does not show a measured transport rate.

How the Medication Changes Signalling

Sertraline inhibits neuronal serotonin reuptake. This changes serotonin availability and signalling. The medicine marker in the diagram names that action without showing an exact molecular binding position.

The static teaching diagram separates transport from receptor response. It does not imply that all brain connections respond together or that a clinical response occurs as quickly as a molecular interaction.

A Closer Look at the Molecular Level

Known action: sertraline affects serotonin reuptake. The label describes uptake findings in human platelets and laboratory animal preparations; these findings are not a direct movie of a living human synapse.

Clinical uncertainty: a transporter effect alone cannot explain who will benefit, how long benefit will take, or every side effect. Depression is not established by this diagram to be a simple serotonin shortage. No receptor occupancy or dose-response scale is shown.

Learn more about sertraline

The UK sertraline article explains checked UK uses, product forms and important safety information. Read that article before treating a mechanism diagram as a medicine guide; the pharmacology lesson does not select a treatment.

Sources and References

  1. Lustral 100 mg: UK SmPC

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom.

  2. What Is a Neurotransmitter?

    Scope: International scientific education; not UK regulatory evidence.

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top